Health Sciences

BD (Becton Dickinson) is one of the largest global medical technology companies in the world, dedicated to innovation in medical discovery, diagnostics and the delivery of care. The company develops technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD’s global sales in 2022 were $4.76 billion.

Positioning a Global Leader in Medical Devices
BD’s Medical and Pharmaceutical Systems Division asked CONTENTI to conduct a positioning workshop and produce a strategic positioning roadmap and messages.

Repositioning BD’s Vaccine Line
CONTENTI was asked by BD to assist in repositioning its line of drug delivery devices aimed at the vaccine market.

Developing Web Content and Claims in a Regulated Environment
CONTENTI was commissioned to provide comprehensive web content to populate the Medical and Pharmaceutical Systems site.

Supporting BD’s Digital Vision
Over the last few years, CONTENTI has provided insights and deliverables for a number of projects aligning BD’s offer with the Pharma 4.0 digitalisation paradigm.

Supporting BD’s Biopharma Range
CONTENTI provided omni-channel marketing and communications support for the full injection device line for biopharma.

In-depth Articles on BD’s Technical and Scientific Breakthroughs
CONTENTI has written numerous articles for BD in the professional Press. CONTENTI manages the briefing, drafting and validation phases, taking the burden off of internal BD staff.

Aptar Pharma is the drug delivery division of the Aptar Group, a United States-based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries. Aptar Group had sales of $3.32 billion in 2022.

New Positioning and Tagline
Aptar Pharma asked CONTENTI to undertake a competitive analysis and extensive internal interviews towards repositioning Aptar Pharma to reflect a new period of expansion. Deliverables included a new corporate tagline reflecting the new brand positioning.

PR and Advertising
CONTENTI drafted the corporate press release and produced an advertising campaign to communicate Aptar’s expansion.

Corporate Launch Event Support
CONTENTI provided communications support for Aptar Pharma’s expansion program launch events, including messaging for key presentations, invitations and other deliverables.

Advanced Instruments is the unsurpassed leader in the North American biotechnology processing and osmolology equipment market and a global provider of scientific and analytical solutions for the bioprocessing and clinical industries.
Preparing Advanced Instruments for EMEA Expansion
Advanced Instruments recently commissioned CONTENTI to update its brand as the company positions itself for rapid growth in the EMEA region.



CONTENTI contact Information:
+33 1 40 09 xx xx
global@contenticorp.com
CONTENTI Corporation
3 Place du PERE CHAILLET, Paris, 75011
FRANCE